Minocycline mitigates the effect of neonatal hypoxic insult on human brain organoids
Source Boisvert et al., 2019 · Yale University School of Medicine · 10.1038/s41419-019-1553-x
Abstract
This protocol describes the generation of self-directed human brain organoids from H9 hESCs over 6 months of culture. The organoids develop forebrain and cortical markers with proper layer organization. The protocol enables modeling of neonatal hypoxic injury and evaluation of therapeutic interventions such as minocycline.
Protocol overview
29 steps across 7 phases
- 1 Maintain H9 hESCs on matrigel substrate
- 2 Prepare hESCs for dissociation
- 3 Wash and rinse cells from substrate
- 4 Transfer cells to ultra-low attachment flask
- 1 Pool cells on day 1
- 2 Further reduce bFGF on day 3
- 3 Switch to neural induction media on day 5
- 1 Maintain organoids in neural induction media
- 2 Harvest samples at designated time points
- 1 Set up hypoxia chamber
- 2 Transfer organoids to hypoxic conditions
- 3 Perform gene expression time course
- 1 Prepare minocycline stock solution
- 2 Set up severe hypoxia and treatment groups
- 3 Calibrate severe hypoxia chamber to 1% oxygen
- 4 Expose organoids to 1% oxygen for 72 hours
- 5 Harvest samples for analysis
- 1 Extract RNA from organoid samples
- 2 Quantify RNA and synthesize cDNA
- 3 Perform qRT-PCR
- 4 Calculate relative gene expression
- 5 Perform statistical analysis
- 1 Fix organoid samples
- 2 Cryoprotect organoids with sucrose gradient
- 3 Embed organoids in OCT and section
- 4 Block and incubate with primary antibody
- 5 Wash and incubate with secondary antibody
- 6 Apply DAPI stain and final washes
- 7 Mount and image
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Boisvert et al., 2019. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol